Clinicopathological Behavior of Single Focus Prostate Adenocarcinoma

Journal of Urology

Volumn 182, Issue 6, 2009, Pages 2689-2694

  Rice, Kevin R ^a   Furusato, Bungo ^b,c   Chen, Yongmei ^c   McLeod, David G ^a,c   Sesterhenn, Isabell A ^b   Brassell, Stephen A ^a,c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c Uniformed Services University of the Health Sciences   (United States)

Author keywords

local; neoplasm recurrence; outcome assessment (health care); prostate; prostatectomy; prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; TREATMENT OUTCOME; TUMOR VOLUME;

ADENOCARCINOMA; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 71849106147     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.08.055     Document Type: Article

References (17)

1. Byar D.P., and Mostofi F.K. Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer 30 (1972) 5
2. Arora R., Koch M.O., Eble J.N., et al. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 100 (2004) 2362
3. Noguchi M., Stamey T.A., McNeal J.E., et al. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol 166 (2001) 104
4. Allan R.W., Sanderson H., and Epstein J.I. Correlation of minute (0.5 MM or less) focus of prostate adenocarcinoma on needle biopsy with radical prostatectomy specimen: role of prostate specific antigen density. J Urol 170 (2003) 370
5. Furusato B., Gao C.L., Ravindranath L., et al. Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer. Mod Pathol 21 (2008) 67
6. Chen M.E., Johnston D., Reyes A.O., et al. A streamlined three-dimensional volume estimation method accurately classifies prostate tumors by volume. Am J Surg Pathol 27 (2003) 1291
7. Stanford J.L., Stephenson R.A., Coyle L.M., et al. Prostate Cancer Trends 1973-1995. National Institutes of Health Publication No. 99-4543 (1999), National Cancer Institute, SEER Program, Bethesda
8. Bruce R.G., Rankin W.R., Cibull M.L., et al. Single focus of adenocarcinoma in the prostate biopsy specimen is not predictive of the pathologic stage of disease. Urology 48 (1996) 75
9. Schulte R.T., Wood D.P., Daignault S., et al. Utility of extended pattern prostate biopsies for tumor localization: pathologic correlations after radical prostatectomy. Cancer 113 (2008) 1559
10. Guzzo T.J., Vira M., Hwang W.T., et al. Impact of multiple biopsy cores on predicting final tumor volume in prostate cancer detected by a single microscopic focus of cancer on biopsy. Urology 66 (2005) 361
11. Crawford E.D., Wilson S.S., Torkko K.C., et al. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy. BJU Int 96 (2005) 999
12. Onik G., and Barzell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 26 (2008) 506
13. Fine S.W., and Epstein J.I. A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score. J Urol 179 (2008) 1335
14. Onik G., Vaughan D., Lotenfoe R., et al. The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 26 (2008) 500
15. Cooperberg M.R., Lubeck D.P., Meng M.V., et al. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 22 (2004) 2141
16. Mouraviev V., Mayes J.M., Sun L., et al. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 110 (2007) 906
17. Mehra R., Tomlins S.A., Yu J., et al. Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer. Cancer Res 68 (2008) 3584